Orexigen Diet Pill to wait more for FDA’s Decision
Shares of Orexigen Therapeutics tumbled more than 16% in morning trading Wednesday after regulators extended by three months a review of its experimental weight loss drug treatment. The Food and Drug Administration is now expected to make a decisi ...
